Psychiatry · New York, NY
NPI
1598841371
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
910 Park Ave
New York, NY, 10021
Phone (212) 517-3900
Medicare paid, 2024
$125K
1,291 services
Medicare patients, 2024
149
Average age 75
Drug cost, 2024
$939K
3,362 prescriptions
Company payments, 2025
$182K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ulla K Laakso was code 99214 (office e&m - established), 940 times for 140 patients. In total Ulla K Laakso billed 1,291 services in 6 codes, and Medicare paid $125K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 940 | 140 | $104.30 | $98K |
| 99213 Office E&M - Established | Office | 149 | 55 | $74.33 | $11K |
| 99443 Telephone Services | Office | 140 | 38 | $83.33 | $12K |
| 99442 Telephone Services | Office | 43 | 26 | $43.29 | $1,861 |
| 90791 Psychotherapy - Nongroup | Office | 11 | 11 | $141.34 | $1,555 |
By year: 2022 $139K for 1,525 services; 2023 $134K for 1,419 services; 2024 $125K for 1,291 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ulla K Laakso prescribed most often to Medicare patients was Clonazepam, with 233 prescriptions and refills. In total Ulla K Laakso wrote 3,362 Medicare prescriptions that cost $939K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clonazepam Generic | 233 | 234 | 37 | $1,760 |
| Quetiapine Fumarate Er Quetiapine Fumarate | 201 | 233 | 21 | $8,930 |
| Zolpidem Tartrate Generic | 199 | 199 | 28 | $1,444 |
| Divalproex Sodium Er Divalproex Sodium | 195 | 261 | 35 | $8,700 |
| Divalproex Sodium Generic | 183 | 247 | 36 | $3,571 |
| Trazodone Hcl Generic | 159 | 231 | 31 | $1,779 |
| Lybalvi Olanzapine/Samidorphan Malate | 120 | 122 | 17 | $187K |
| Mirtazapine Generic | 116 | 154 | 16 | $937 |
| Quetiapine Fumarate Generic | 112 | 140 | 18 | $1,760 |
| Escitalopram Oxalate Generic | 94 | 118 | 17 | $788 |
| Alprazolam Generic | 91 | 91 | 13 | $422 |
| Lithium Carbonate Generic | 88 | 136 | 16 | $606 |
| Lorazepam Generic | 80 | 80 | Under 11 | $925 |
| Gabapentin Generic | 75 | 149 | 20 | $1,901 |
| Propranolol Hcl Generic | 67 | 75 | 11 | $561 |
Brand drugs: 510 claims; generic drugs: 2,852 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ulla K Laakso $182K ($182K in general payments such as food, travel and fees) from 20 companies. The largest payer was Vanda Pharmaceuticals Inc. with $49K.
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. VNDA | 74 | $49K |
| Alkermes, Inc. ALKS | 55 | $28K |
| Otsuka America Pharmaceutical, Inc. 4578.T | 31 | $20K |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 33 | $20K |
| E.R. Squibb & Sons, L.L.C. BMY | 63 | $19K |
| Axsome Therapeutics, Inc. AXSM | 41 | $15K |
| Supernus Pharmaceuticals, Inc. SUPN | 21 | $12K |
| Abbvie Inc. ABBV | 40 | $8,269 |
| Tris Pharma Inc | 44 | $7,682 |
| Lundbeck LLC | 47 | $897 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.